Bayshore Networks Receives 2017 IoT Evolution Product of the Year Award
Jul 25, 2017 11:35 am UTC| Business
BETHESDA, Md., July 25, 2017 -- Bayshore Networks, the leading provider of cyber protection for industrial infrastructure, today announced that the Bayshore Industrial Cyber Protection Platform has received a 2017 IoT...
First National Corporation Announces 23% Increase in Second Quarter Net Income
Jul 25, 2017 11:30 am UTC| Business
STRASBURG, Va., July 25, 2017 -- First National Corporation (the “Company” or “First National”) (OTC:FXNC) today reported net income of $1.8 million and earnings per share of $0.36 for the second quarter ended June 30,...
Jul 25, 2017 11:30 am UTC| Business
ATHENS, Greece, July 25, 2017 -- Diana Containerships Inc. (NASDAQ:DCIX), (the “Company”), a global shipping company specializing in the ownership of containerships, today reported net income of $36.5 million, and...
Trek Mining Continues to Intersect Significant Gold Mineralization at Piaba West
Jul 25, 2017 11:30 am UTC| Business
VANCOUVER, British Columbia, July 25, 2017 -- Trek Mining Inc. (TSX-V:TREK) (“Trek Mining” or “the Company”) is pleased to announce positive results from an additional 30 shallow step-out and infill drill holes...
Lincoln Electric Reports Second Quarter 2017 Results
Jul 25, 2017 11:30 am UTC| Business
Second Quarter 2017 Highlights- Organic sales increase 5.8%- Operating income margin of 14.0%, 14.7% on an adjusted basis- EPS of $0.92, Adjusted EPS of $0.97 CLEVELAND, July 25, 2017 -- Lincoln Electric...
Amicus Therapeutics to Announce Second Quarter 2017 Financial Results on August 7, 2017
Jul 25, 2017 11:30 am UTC| Business
CRANBURY, N.J., July 25, 2017 -- Amicus Therapeutics (Nasdaq:FOLD) today announced a conference call and live audio webcast on August 7, 2017 at 8:30 a.m. ET to discuss financial results for the second quarter ended...
Pacira Announces Topline Phase 3 Results for EXPAREL® as a Single-dose Nerve Block
Jul 25, 2017 11:30 am UTC| Business
Upper extremity study showed that EXPAREL significantly reduces pain scores and opioid use Lower extremity study defined safety and pharmacokinetic profile through 120 hours Timing for resubmission of supplemental New...